U.S. Healthcare Analytics Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026

October 2018 | 100 pages | ID: U947D16159BEN
Data Bridge Market Research

Abstracts

U.S. healthcare analytics market is projected to register a healthy CAGR of 15.9% in the forecast period of 2019 to 2026.

Market Segmentation

By Type (Prescriptive Analytics, Predictive Analytics, Descriptive Analytics), Component (Services, Software, Hardware), Delivery Model (On-Demand, On-Premise), Application (Clinical Analytics, Population Health Analytics, Operational and Administrative Analytics, Financial Analytics), End User (Healthcare Payers, Healthcare Providers and ACOS, HIES, MCOS, AND TPAS)

Major growing sectors under the Market Segmentation are as follows:

• In type, the prescriptive analytics are highly used because it helps to forecasts future trends and helps in predicting the values of missing fields in a data set and probable impact of data changes on future trends.
• In component, services are growing at the highest CAGR because the services provided the essential resource for applications that include hardware, software and other technical aspects.
• In delivery model, on-demand is growing with highest CAGR rate because it is easier to get started and has a lower ownership cost.
• In application, population health analytics is growing with highest CAGR because it is increasingly being used as a tool for preventive and wellness management among other applications.
• In End user, Healthcare Payers is growing at the highest CAGR because healthcare payers will be more in number than the providers because when the services will be provided once the payers invest in it.

Key Market Players

The Key Market Players for U.S. Healthcare Analytics Market are listed below:

• IBM
• Wipro Limited
• Allscripts
• Cerner Corporation
• SAS Institute Inc.
• SCIOInspire, Corp.
• Verscend Technologies Pvt. Ltd
• CitiusTech Inc.
• Vitreos Health
• Ikon Tech
• IQVIA
• GENERAL ELECTRIC

Contents

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.S. HEALTHCARE ANALYTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 RESEARCH METHODOLOGY
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 SECONDARY SOURCES
2.7 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS
  5.1.1 GOVERNMENT INITATIVES TO ENCOURAGE USE OF ELECTRONIC HEALTH RECORDS
  5.1.2 INTRODUCTION OF NEW SOLUTIONS AND SERVICES IN HEALTHCARE ANALYTICS
  5.1.3 ENTRY OF BIG DATA INTO HEALTHCARE
  5.1.4 GROWING NEED TO CURB HEALTHCARE SPENDING WITH BETTER CLINICAL OUTCOMES
5.2 RESTRAINT
  5.2.1 LESS NUMBER OF SKILLED PERSONNEL
5.3 OPPORTUNITIES
  5.3.1 GROWING AWARENESS ABOUT ANALYTICS IN VALUE AND PRECISION BASED CARE
  5.3.2 INCREASE IN CLOUD BASED ANALYTICS
  5.3.3 INCREASING IMPACT ON HEALTHCARE INDUSTRY DUE TO SOCIAL MEDIA
  5.3.4 RISING PATIENT REGISTRIES
5.4 CHALLENGES
  5.4.1 DATA CONFIDENTIALITY
  5.4.2 ISSUES IN DATA ACCURACY AND CONSISTENCY
  5.4.3 DATA INTEGRATION
  5.4.4 FUNCTIONING GAP BETWEEN THE PROVIDERS AND PAYERS

6 U.S. HEALTHCARE ANALYTICS MARKET, BY TYPE

6.1 OVERVIEW
6.2 PRESCRIPTIVE ANALYTICS
6.3 PREDICTIVE ANALYTICS
6.4 DESCRIPTIVE ANALYTICS

7 U.S. HEALTHCARE ANALYTICS MARKET, BY COMPONENT

7.1 OVERVIEW
7.2 SERVICES
  7.2.1 SUPPORT SERVICES
  7.2.2 BUSINESS ANALYTICS SERVICES
7.3 SOFTWARE
7.4 HARDWARE

8 U.S. HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL

8.1 OVERVIEW
8.2 ON-DEMAND
8.3 ON-PREMISE

9 U.S. HEALTHCARE ANALYTICS MARKET, BY APPLICATION

9.1 OVERVIEW
9.2 CLINICAL ANALYTICS
  9.2.1 REGULATORY REPORTING AND COMPLIANCE
  9.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING
  9.2.3 CLINICAL DECISION SUPPORT
  9.2.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS
  9.2.5 PRECISION HEALTH
9.3 POPULATION HEALTH ANALYTICS
  9.3.1 POPULATION CARE MANAGEMENT
  9.3.2 POPULATION RISK MANAGEMENT
  9.3.3 PATIENT ENGAGEMENT
  9.3.4 CLINICAL OUTCOME MANAGEMENT
  9.3.5 ACTIVITY-BASED COSTING
9.4 FINANCIAL ANALYTICS
  9.4.1 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA)
  9.4.2 REVENUE CYCLE MANAGEMENT (RCM)
  9.4.3 RISK ADJUSTMENT AND RISK ASSESSMENT
  9.4.4 CLAIMS PROCESSING
9.5 OPERATIONAL AND ADMINISTRATIVE ANALYTICS
  9.5.1 SUPPLY CHAIN ANALYTICS
  9.5.2 WORKFORCE ANALYTICS
  9.5.3 RESEARCH ANALYTICS
  9.5.4 MARKET INTELLIGENCE
  9.5.5 ENTERPRISE PERFORMANCE
  9.5.6 STRATEGIC ANALYTICS

10 U.S. HEALTHCARE ANALYTICS MARKET, BY END USER

10.1 OVERVIEW
10.2 HEALTHCARE PAYERS
  10.2.1 GOVERNMENT AGENCIES
  10.2.2 PRIVATE INSURANCE COMPANIES
  10.2.3 EMPLOYERS AND PRIVATE EXCHANGES
10.3 HEALTHCARE PROVIDERS
  10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
  10.3.2 AMBULATORY SETTINGS
  10.3.3 POST-ACUTE CARE ORGANIZATIONS
10.4 ACOS, HIES, MCOS AND TPAS

11 U.S. HEALTHCARE ANALYTICS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: U.S.

12 COMPANY PROFILES

12.1 ALLSCRIPTS
  12.1.1 COMPANY OVERVIEW
  12.1.2 REVENUE ANALYSIS
  12.1.3 PRODUCT PORTFOLIO
  12.1.4 RECENT DEVELOPMENTS
12.2 OPTUM INC.
  12.2.1 COMPANY OVERVIEW
  12.2.2 GEOGRAPHICAL PRESENCE
  12.2.3 PRODUCT PORTFOLIO
  12.2.4 RECENT DEVELOPMENTS
12.3 ORACLE
  12.3.1 COMPANY OVERVIEW
  12.3.2 REVENUE ANALYSIS
  12.3.3 PRODUCT PORTFOLIO
  12.3.4 RECENT DEVELOPMENTS
12.4 CERNER
  12.4.1 COMPANY OVERVIEW
  12.4.2 REVENUE ANALYSIS
  12.4.3 PRODUCT PORTFOLIO
  12.4.4 RECENT DEVELOPMENTS
12.5 CITIUSTECH INC.
  12.5.1 COMPANY OVERVIEW
  12.5.2 GEOGRAPHICAL PRESENCE
  12.5.3 PRODUCT PORTFOLIO
  12.5.4 RECENT DEVELOPMENTS
12.6 WIPRO LIMITED
  12.6.1 COMPANY SNAPSHOT
  12.6.2 REVENUE ANALYSIS
  12.6.3 PRODUCT PORTFOLIO
  12.6.4 RECENT DEVELOPMENTS
12.7 VITREOSHEALTH
  12.7.1 COMPANY SNAPSHOT
  12.7.2 GEOGRAPHICAL PRESENCE
  12.7.3 PRODUCT PORTFOLIO
  12.7.4 RECENT DEVELOPMENTS
12.8 SCIO HEALTH ANALYTICS
  12.8.1 COMPANY SNAPSHOT
  12.8.2 GLOBAL PRESENCE
  12.8.3 PRODUCT PORTFOLIO
  12.8.4 RECENT DEVELOPMENTS
12.9 HEALTHCARE CATALYST
  12.9.1 COMPANY SNAPSHOT
  12.9.2 GEOGRAPHICAL PRESENCE
  12.9.3 PRODUCT PORTFOLIO
  12.9.4 RECENT DEVELOPMENTS
12.10 GE HEALTHCARE
  12.10.1 COMPANY SNAPSHOT
  12.10.2 REVENUE ANALYSIS
  12.10.3 PRODUCT PORTFOLIO
  12.10.4 RECENT DEVELOPMENTS
12.11 IBM
  12.11.1 COMPANY OVERVIEW
  12.11.2 REVENUE ANALYSIS
  12.11.3 PRODUCT PORTFOLIO
  12.11.4 RECENT DEVELOPMENTS
12.12 INOVALON
  12.12.1 COMPANY OVERVIEW
  12.12.2 REVENUE ANALYSIS
  12.12.3 PRODUCT PORTFOLIO
  12.12.4 RECENT DEVELOPMENTS
12.13 VERSCEND TECHNOLOGIES INC.
  12.13.1 COMPANY OVERVIEW
  12.13.2 GEOGRAPHIC PRESENCE
  12.13.3 PRODUCT PORTFOLIO
  12.13.4 RECENT DEVELOPMENTS
12.14 1MCKESSON CORPORATION
  12.14.1 COMPANY SNAPSHOT
  12.14.2 2REVENUE ANALYSIS
  12.14.3 PRODUCT PORTFOLIO
  12.14.4 RECENT DEVELOPMENTS
12.15 SAS INSTITUTE
  12.15.1 COMPANY OVERVIEW
  12.15.2 REVENUE ANALYSIS
  12.15.3 PRODUCT PORTFOLIO
  12.15.4 RECENT DEVELOPMENTS
12.16 IKON-TECH
  12.16.1 COMPANY OVERVIEW
  12.16.2 PRODUCT PORTFOLIO
  12.16.3 RECENT DEVELOPMENTS
12.17 IQVIA
  12.17.1 COMPANY SNAPSHOT
  12.17.2 REVENUE ANALYSIS
  12.17.3 PRODUCT PORTFOLIO
  12.17.4 RECENT DEVELOPMENTS

13 RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1 THE U.S HAS THE FOLLOWING LAWS FOR DATA SAFETY OF PATIENTS:
Table 2 U.S. HEALTHCARE ANALYTICS MARKET, BY TYPE, 2017-2026( USD MILLION)
Table 3 U.S. HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2017-2026( USD MILLION)
Table 4 U.S. HEALTHCARE ANALYTICS MARKET, SERVICES, BY COMPONENT, 2017-2026 (USD MILLION)
Table 5 U.S. HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2026( USD MILLION)
Table 6 U.S. HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 7 U.S. HEALTHCARE ANALYTICS MARKET, CLINICAL ANALYTICS, BY APPLICATION, 2017-2026 (USD MILLION)
Table 8 U.S. HEALTHCARE ANALYTICS MARKET, POPULATION HEALTH ANALYTICS, BY APPLICATION, 2017-2026( USD MILLION)
Table 9 U.S. HEALTHCARE ANALYTICS MARKET, FINANCIAL ANALYTICS, BY APPLICATION, 2017-2026( USD MILLION)
Table 10 U.S. HEALTHCARE ANALYTICS MARKET, OPERATIONAL AND ADMINISTRATIVE ANALYTICS, BY APPLICATION, 2017-2026( USD MILLION)
Table 11 U.S. HEALTHCARE ANALYTICS MARKET, BY END-USER, 2017-2026( USD MILLION)
Table 12 U.S. HEALTHCARE ANALYTICS MARKET, HEALTHCARE PAYERS, BY END-USER, 2017-2026( USD MILLION)
Table 13 U.S. HEALTHCARE ANALYTICS MARKET, HEALTHCARE PROVIDERS, BY END-USER, 2017-2026( USD MILLION)

List Of Figures

LIST OF FIGURES

Figure 1 U.S. HEALTHCARE ANALYTICS MARKET : SEGMENTATION
Figure 2 U.S. HEALTHCARE ANALYTICS MARKET: DATA TRIANGULATION
Figure 3 U.S. HEALTHCARE ANALYTICS MARKET: RESEARCH SNAPSHOT
Figure 4 U.S. HEALTHCARE ANALYTICS MARKET BOTTOM UP APPROACH
Figure 5 U.S. HEALTHCARE ANALYTICS MARKETTOP DOWN APPROACH
Figure 6 U.S. HEALTHCARE ANALYTICS MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 U.S. HEALTHCARE ANALYTICS MARKET: SEGMENTATION
Figure 8 U.S. HEALTHCARE ANALYTICS MARKET, 2018
Figure 9 GOVERNMENT INITIATIVES TO ENCOURAGE THE USE OF ELECTRONIC HEALTH RECORDS AND ENTRY OF BIG DATA INTO HEALTHCARE ARE EXPECTED TO DRIVE THE MARKET FOR U.S. HEALTHCARE ANALYTICS IN THE FORECAST PERIOD

2019 TO 2026

Figure 10 PREDICTIVE ANALYTICS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. HEALTHCARE ANALYTICS MARKET IN 2019 & 2026
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF U.S. HEALTHCARE ANALYTICS MARKET
Figure 12 U.S. HEALTHCARE ANALYTICS MARKET: BY TYPE, 2018
Figure 13 U.S. HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2018
Figure 14 U.S. SERVICES IN HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2018
Figure 15 U.S. HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL, 2018
Figure 16 U.S. HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2018
Figure 17 U.S. HEALTHCARE ANALYTICS MARKET, BY END USER, 2018
Figure 18 U.S. HEALTHCARE ANALYTICS MARKET, COMPANY LANDSCAPE 2018 (%)